Best Diversified Pharmaceuticals Companies in Hyderabad, India
The 35 best Diversified Pharmaceuticals companies in Hyderabad, India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Orbicular Pharmaceutical Technologies.
Ranked: Best Diversified Pharmaceuticals companies in Hyderabad
| # | Company | Disclosed funding | Revenue | Revenue YoY | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Hetero Healthcare Manufacturer of generic pharmaceuticals, including oncology and antiretroviral drugs | — | $141M FY2025 | +16% | 3,923 | 2006 | L Padmanabhan CEO | 8 patents Stable injectable and transdermal dosage forms for anti-inflammatory and anticancer drugs | — |
| 2 | Virchow Biotech Recombinant products for wound care, osteoporosis & periodontal disorders | — | $90M FY2025 | +5% | 1,273 | 2001 | Ravi Gattupalli CEO | 7 patents Ophthalmic drug delivery devices and multi‑dose heparin pharmaceutical packaging systems | — |
| 3 | TAGOOR Manufacturer of drugs and their intermediates | — | $68M FY2025 | +9% | 1,496 | 2005 | Satya Chief Executive Officer | — | — |
| 4 | Emnar Pharma Pharmaceutical company that manufactures and supplies active pharmaceutical ingredients, intermediates, and… | — | $47M FY2025 | — | 394 | 2005 | Ravi Dutt Sharma Managing Director | — | — |
| 5 | Fusion Healthcare Manufacturer of solid and liquid generic formulations | — | $40M FY2025 | +17% | 909 | 2007 | Madhu Ramadugu Founder & Managing Director | — | — |
| 6 | Orbicular Pharmaceutical Technologies Manufacturer of niche generic and specialty pharmaceutical products | $20M | $32M FY2025 | +41% | 203 203 → 260 (+28%) | 2010 | M Mohan Co-Founder & MD | 30 patents Injectable drug delivery devices and stable viscous pharmaceutical formulations | — |
| 7 | Vivin Drugs & Pharmaceuticals Manufacturer of advanced and conventional drugs, pharmaceutical ingredients, and intermediates. | — | $20M FY2023 | -25% | 203 | 2011 | Anuradha B Managing Director | — | — |
| 8 | Azico Biophore R&D company focused on manufacturing of API for multiple therapeutic areas | $5M | $19M FY2025 | +14% | 66 | 2008 | Rajesh Joshi Co-Founder & Managing Director | 5 patents Efficient chemical synthesis processes for levothyroxine sodium (thyroid hormone drug) | — |
| 9 | Sanzyme Biologics Sanzyme is a biotech healthcare company. | — | $18M FY2025 | -27% | 175 | 1969 | Prasad Kompella CEO | 19 patents Patents concentrated in health & consumer products | — |
| 10 | Roopa Industries Traditional company manufacturing nutraceuticals, bulk drugs and chemicals | — | $15M FY2025 | +72% | 32 | 2000 | Tumbalam Gooty Raghavendra CEO & MD | 6 patents Secure DRM and rights enforcement for scheduled live streaming events | — |
| 11 | Power Pharma Innovating technologies for carbon-free energy and medical radioisotopes extraction | — | $13M FY2025 | +6% | 73 | 2017 | — | — | — |
| 12 | SURAKSHA Pharmaceutical, neutraceutical and cosmetics conglomerate | — | $12M FY2025 | +24% | 114 | 1998 | Nageswara Gupta Manepalli Managing Director | — | — |
| 13 | Credo Life Provider of specialized pellet and taste mask granules for global markets | — | $11M FY2025 | -6% | 194 | 2014 | Aluru Prasad Founder & Managing Director | — | — |
| 14 | Therallen Pharma Research driven drug delivery systems company with a focus on new product development | — | $6M FY2025 | +34% | 67 | 2017 | — | — | — |
| 15 | Vannsh Life Sciences Specialty pharmaceutical company engaged in integrated research, development, and manufacturing of medicines | — | $6M FY2024 | — | 79 | 2009 | — | — | — |
| 16 | Tusker Pharma Manufacturer of pharmaceuticals for health & wellness | — | $6M FY2019 | +261% | — | 2015 | Nikhil Chintalapati Founder | — | — |
| 17 | Questus Pharma Pharmaceutical company that specializes in the development and manufacturing of patient-centric formulations… | — | $5M FY2025 | -10% | 110 110 → 55 (-50%) | 2021 | — | — | — |
| 18 | Sunrise International Labs Branded generics, Formulations and OTC drugs. | — | $4M FY2021 | — | 68 | 1986 | Samir Garud CEO | — | — |
| 19 | Combat Drugs Pharmaceutical company manufacturing formulations and offering custom manufacturing services | — | $3M FY2025 | -34% | 1 | 1986 | — | — | — |
| 20 | Suven Life Sciences CDMO services, also having a discovery pipeline of CNS drugs | — | $2M FY2025 | -47% | 145 | 1989 | — | 1,255 patents 5‑HT4 receptor agonist pyrrolo‑pyridazinones for dementia and cognitive disorder therapeutics | — |
| 21 | Vilin Bio Med R&D company focused on manufacturing drugs for multiple therapeutic areas | — | $2M FY2022 | — | 14 | 2022 | — | — | — |
| 22 | Credo Pharma Manufacturer and supplier of pharmaceuticals | — | $254K FY2025 | +10% | — | 2013 | Kandru Madhavarao Co-Founder & Director | — | — |
| 23 | GeneSys Biologics R&D company focused on manufacturing of insulin biosimilars for multiple therapeutic areas | $17M | $243K FY2025 | -66% | 242 | 2014 | Venkat Reddy Yelma Managing Director | — | — |
Top 4 Diversified Pharmaceuticals companies in Hyderabad
#1
Late Stage · Hyderabad, Telangana · founded 2010 · 203 employees$20Mraised▾
Orbicular Pharmaceutical Technologies offers niche generic and specialty pharmaceutical products. They manufacture injectables, topicals, ophthalmic, parenteral, nasal sprays, and inhalation. Their products include microspheres, nanosuspensions, nano-emulsions, liposomes, peptide, etc.
- May 2024PE$20M
#2
Seed · Hyderabad, Telangana · founded 2017$44.3Kraised▾
Developer of nanomedicine phytopharmaceuticals & biopharmaceuticals for immunology and smart devices addressing sustainable wellness. The company invested in R&D aimed at combating vector-borne diseases with an ambitious goal of eradicating malaria through hepatic targeted nanoencapsulated phytopharmaceuticals. Its AI-powered vector surveillance devices offers real-time mosquito monitoring in homes, malls, schools, and hospitals.
- Jan 2026Seed$44.3K
#3
Seed · Hyderabad, Telangana · founded 2014 · 242 employees$16.7Mraised▾
R&D company focused on manufacturing of insulin biosimilars for multiple therapeutic areas
- Oct 2021Seed$16.2M
- Feb 2020Angel$459.9K
#4
Seed · Hyderabad, Telangana · founded 2008 · 66 employees$5.2Mraised▾
R&D company focused on manufacturing of API for multiple therapeutic areas
- Apr 2016Seed$1.3M
- Jun 2014Seed$1.9M
- Oct 2013Angel$983.9K
- Mar 2012Angel$948.1K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Diversified Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising